End of Life & Psilocybin Therapy - Thomas Hartle

<p>Today we meet with Thomas Hartle, who was granted a federal exemption to use psilocybin mushrooms as a therapy for anxiety surrounding his Stage 4 colon cancer. Thomas has exhibited profound benefit from a session with psilocybin, which was legally facilitated by a company called TheraPsil. We have the honor to sit down with him to hear about his journey before, during and after the therapy. <br/>.</p><p>Thomas Hartle is a 52-year-old father of two based in Saskatoon. He was diagnosed in 2016 and has had numerous rounds of  chemotherapy. Thomas is a welcoming, optimistic person and has invited folks in a similar position to connect with him. </p><p><b>Topics Covered:</b></p><ul><li>Legislation of psilocybin assisted therapy in Canada</li><li>Psychotherapy and the unpredictable nuances in a given patient</li><li>Psilocybin’s influence on daily life beyond anxiety</li><li>Tips for how to get the most from a session with psilocybin</li><li>Navigating family dynamics as a cancer patient and as recipient of psychotherapy</li><li>TheraPsil, a patient advocacy group offering psilocybin to eligible patients in Canada</li><li>Existence after death</li></ul><p><br/></p><p><b>Show notes:</b></p><p><a href='https://therapsil.ca/'>https://therapsil.ca/</a></p><p><a href='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367557/'>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367557</a></p><p><a href='https://www.facebook.com/thomas.hartle'>https://www.facebook.com/thomas.hartle</a></p><p><br/></p>